D019804Chemicals & DrugsD02.241.223.100.050.300.500D02.241.223.100.300.595.100.540D02.241.511.390.595.100.540D02.455.426.559.389.127.020.452.750D02.455.426.559.389.127.281.595.100.540D02.455.426.559.389.657.410.595.100.540330.998043Mesalaminecmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMDJohnRosenJohn M. Rosen0.000000000000000.0000000000000089Rosen, John0000-0003-4291-3214Director of Telemedicine and Outreach0.2398540.05996343research area of0.3686790.2403242subject area for2Associate Professor1ProfessorSurgeryMD, FAAP, FACGThomasAttardThomas M. Attard0.000000000000000.00000000000000132Attard, ThomasMedical Director Polyposis Center19633577Quiros JA, Heyman MB, Pohl JF, Attard TM, Pieniaszek HJ, Bortey E, Walker K, Forbes WPJournal of pediatric gastroenterology and nutritionQuiros JA, Heyman MB, Pohl JF, Attard TM, Pieniaszek HJ, Bortey E, Walker K, Forbes WP. Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study. J Pediatr Gastroenterol Nutr. 2009 Nov; 49(5):571-9.J Pediatr Gastroenterol Nutr2009-11-01T00:00:002009Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.PediatricsClinicalChildren's Mercy Kansas CitySurgeryMD, MS, FACS, FAAPRebeccaRenteaRebecca M. Rentea0.000000000000000.00000000000000169Rentea, Rebecca0000-0002-8689-5989Director, Comprehensive Colorectal Centertrue1Director, Comprehensive Colorectal CenterDirector, Comprehensive Colorectal Center37652182Lupo AM, Lawson AA, Rentea RM, Kapalu CL, Rosen JMJournal of pediatric and adolescent gynecologyLupo AM, Lawson AA, Rentea RM, Kapalu CL, Rosen JM. Intravaginal Mesalamine Administration: A Novel Technique for Neovaginal Colitis. J Pediatr Adolesc Gynecol. 2024 Feb; 37(1):93-94.J Pediatr Adolesc Gynecol2023-08-30T00:00:002023Intravaginal Mesalamine Administration: A Novel Technique for Neovaginal Colitis.true1Medical Director Polyposis CenterMedical Director Polyposis Centertrue1Director of Telemedicine and OutreachDirector of Telemedicine and Outreach